Depressive Disorder, Major: all 2,805 studies
Page 21 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.
- Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive DisorderStatus unknownNCT02934035
- Music Therapy for Major Depressive Disorder Residual SymptomsStatus unknownNCT02925325Not applicable
- Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)CompletedNCT02922556Not applicable
- A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive DisorderCompletedNCT02919579Phase 1
- Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive DisorderCompletedNCT02919501Phase 2
- The Treatment of Depression With Yoga and WalkingCompletedNCT02907476Not applicable
- A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive DisorderCompletedNCT02902601Phase 1
- ESTIA: Computerized Intervention Targeting Cognitive Control Deficits in Depressed AdultsCompletedNCT02891564Not applicable
- Selenium as Augmentation Treatment for Sertraline Resistant Major DepressionSuspendedNCT02890212Not applicable
- Behavioral Activation + Cognitive Processing Therapy for PTSD and Comorbid MDDCompletedNCT02874131Not applicable
- Psychotherapeutic Text Messaging for Depression Pilot StudyCompletedNCT02872454Not applicable
- Multimodal Imaging of ECT EffectsCompletedNCT02871141
- Treatment Outcome in Major Depressive DisorderCompletedNCT02869035Phase 1
- A Trial of Dextromethorphan for Treatment of Major Depressive DisorderCompletedNCT02860962Phase 1
- Cognitive Behavioral Group Therapy for the Management of Menopause Symptoms in Mood DisordersCompletedNCT02860910Not applicable
- Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine TreatmentCompletedNCT02859103Phase 4
- Blood Biomarkers in Suicidal BehaviourCompletedNCT02855918Not applicable
- Integrating Pharmacogenomic Testing Into a Child Psychiatry ClinicCompletedNCT02855580
- Predictive Nature of Total Cholesterol Threshold: Possible Link to Suicidal BehaviorStatus unknownNCT02847741Not applicable
- Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI)WithdrawnNCT02845349Phase 3
- Brain-Based Biomarkers in Response to TMS in MDDCompletedNCT02843373
- The Efficacy, Safety, and Tolerability of Probiotics on the Mood and Cognition of Depressed PatientsCompletedNCT02838043Phase 3
- Computerized Cognitive Behavior Therapy in Treating Depression in Patients With CancerCompletedNCT02837887Not applicable
- Clinical Trial on Efficacy of rTMS to Improve ECT in Treatment-Resistant DepressionCompletedNCT02830399Not applicable
- Loneliness and Occurrence of Suicide Attempts and Suicidal IdeasCompletedNCT02829671Not applicable
- Pain, Reward, Attention and Neurocircuitry: Biomarkers of SuicidalityCompletedNCT02811198
- Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)CompletedNCT02805881Not applicable
- Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant TreatmentCompletedNCT02805439Phase 2
- Maintaining Mechanisms of Chronic Depression and Their ChangeabilityCompletedNCT02801513Not applicable
- Pilot Study Comparing 10hz vs Theta Burst StimulationCompletedNCT02800226Phase 3
- Impact of tDCS on Emotional Processing in Major DepressionCompletedNCT02793258Not applicable
- Ketamine Anesthesia for Improvement of Depression in ECTCompletedNCT02752724Not applicable
- Peripheral Immunomarker Validation in Treatment-resistant DepressionCompletedNCT02752178
- Combining Emotion Regulation and Mindfulness Skills for Preventing Depression RelapseCompletedNCT02747134Not applicable
- Bipolar Proteomic Assay Validation StudyCompletedNCT02746367
- A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive DisorderCompletedNCT02741791Phase 3
- Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients.CompletedNCT02741622Not applicable
- Depression and Immune Function in Multiple Sclerosis (MS)CompletedNCT02740296
- Adolescent Mental Health: Canadian Psychiatric Risk and Outcome StudyCompletedNCT02739932
- Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly PatientsTerminatedNCT02737540
- Imaging SV2A in Mood DisordersActive, not recruitingNCT02734602Not applicable
- Examination of Glutamate and mGluR5 in Psychiatric DisordersCompletedNCT02727972
- A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive DisorderStatus unknownNCT02724735
- Translational Investigation of Gestational Environment on Neurobehavioral Function in ChildrenCompletedNCT02715778
- Disorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal CortexStatus unknownNCT02715128Not applicable
- Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)Status unknownNCT02711215Phase 4
- A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tablets in Chinese Healthy VolunteersCompletedNCT02698553Phase 1
- Study of NSI-189 for Major Depressive DisorderStatus unknownNCT02695472Phase 2
- The Development of Skin Adhesive Patches for the Monitoring and Prediction of Mental DisordersStatus unknownNCT02690324Not applicable
- Treating Major Depressive Disorder With Music and Low-frequency Rhythmic Sensory StimulationCompletedNCT02685982Not applicable
- Multi-center Imaging Genetics Studies in ChinaStatus unknownNCT02681822
- A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual InsomniaStatus unknownNCT02669030Phase 4
- NeuroQore rTMS (Monophasic vs. Biphasic) for Major Depressive Disorder: A Randomized Controlled Pilot TrialCompletedNCT02667041Not applicable
- Open-Label Placebo for the Treatment of DepressionStatus unknownNCT02666989Not applicable
- Chronobiology, Sleep Related Risk Factors and Light Therapy in Perinatal Depression: the Life-ON ProjectCompletedNCT02664467Not applicable
- Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for DepressionCompletedNCT02661789Not applicable
- Ketamine as an Alternative Treatment to ECT in Major Depressive DisorderCompletedNCT02659085Phase 2/3
- The Effect of tDCS in Patients With Moderate to Severe Major Depressive DisorderCompletedNCT02657980Phase 3
- Impact of Immune Challenge on Triple Network Connectivity in HumansStatus unknownNCT02653235Not applicable
- Intra-nasal vs. Intra-venous Ketamine AdministrationCompletedNCT02644629Phase 4
- Vortioxetine for MDD, Cognition, and Systemic Inflammatory BiomarkersWithdrawnNCT02637466Phase 4
- Psychotherapy Plus: Combining Cognitive Behavioral Therapy With tDCSCompletedNCT02633449Not applicable
- Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of DepressionCompletedNCT02624102Phase 3
- Multicomponent Yoga Intervention for Major Depressive DisorderCompletedNCT02616549Phase 2
- Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to BehaviourCompletedNCT02615405Not applicable
- Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia NervosaCompletedNCT02615119Not applicable
- MemFlex to Prevent Depressive RelapseCompletedNCT02614326Phase 2
- Physical EXercise as an Adjunct Treatment for DepressionCompletedNCT02612142Not applicable
- Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental IllnessCompletedNCT02594696Not applicable
- Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.CompletedNCT02593643Early Phase 1
- MetAbolism vaRiability of VEnLafaxineStatus unknownNCT02590185Not applicable
- Predictors of Depression Treatment Response to ExerciseCompletedNCT02583867Phase 3
- Noninvasive Physiologic Sensors to Assess DepressionCompletedNCT02568865
- TNS for Treating Major Depressive Disorder in the ElderlyStatus unknownNCT02562677Phase 1/2
- Jump Step - A Participatory Approach to Physical Activity & Mental WellnessStatus unknownNCT02549547Not applicable
- Predictors of Treatment Response in Late-onset Major Depressive DisorderSuspendedNCT02546024
- Transcranial Direct Current Stimulation (tDCS) As Treatment for Major DepressionCompletedNCT02530164Not applicable
- Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD PatientsCompletedNCT02529462Phase 3
- Heart Rate Variability in DepressionCompletedNCT02525978Not applicable
- Validation of the THINC-it Tool for Cognitive Dysfunction in Major Depressive DisorderCompletedNCT02508493
- Intermittent Theta Burst Stimulation for MDDSuspendedNCT02506127Not applicable
- Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress DisorderCompletedNCT02502604Not applicable
- Modeling and Predicting Real World Behavior Using Mobile Sensor Data on Patients With Major Depressive DisorderCompletedNCT02499094Not applicable
- Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)CompletedNCT02489305
- The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment DepressionCompletedNCT02480400Not applicable
- Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Therapy-based Clinical SettingCompletedNCT02479464Not applicable
- A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive DisorderCompletedNCT02476058Phase 1
- Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic OutcomesCompletedNCT02474680
- Noradrenergic Activity, Cognition and Major Depressive DisorderCompletedNCT02470026Not applicable
- Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive DisorderCompletedNCT02466477Phase 4
- A Study of Intermittent Doses of CERC-301 in MDDCompletedNCT02459236Phase 2
- Adjunct Minocyline in Treatment-resistant DepressionCompletedNCT02456948Phase 2
- Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery DiseaseWithdrawnNCT02454426Early Phase 1
- Mood Patient Powered Research Network (MoodNetwork)CompletedNCT02453438
- Blended Depression Therapy: Cognitive Behaviour Therapy Face-to-face and Via InternetCompletedNCT02449447Not applicable
- Pharmacogenetic Testing on an Outpatient Population With a Depression DiagnosisCompletedNCT02443584Not applicable
- Multimodal MRI Characteristics of Psychotherapy Response in Late Life DepressionCompletedNCT02440815Not applicable
- A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)CompletedNCT02433093Phase 1
- MRI Studies of Emotion in DepressionCompletedNCT02429011
- Therapeutic Effectiveness of Exercise Associated to the Pharmacotherapy in Major DepressionCompletedNCT02427789Not applicable